Pharmanomics

Mehr zum Buch

Exploring the shortcomings of the pharmaceutical industry during a pandemic, this book delves into the failures of Big Pharma and the implications for the global economy. It examines the interplay between corporate interests and public health, highlighting systemic issues that hindered effective responses. By analyzing key events and decisions, the author reveals the lessons learned and the urgent need for reform in health care and economic policies to better prepare for future crises.